It relates to a pharmaceutical composition for preventing or treating fatty liver comprising an HTR2A inhibitor as an active ingredient. The HTR2A inhibitor of the present invention suppresses fatty liver production induced by a high-fat diet and suppresses the expression of genes related to adipogenesis in hepatocytes, so it can be usefully used as an active ingredient in a composition for preventing or treating fatty liver.
展开▼
